When One Ear Falls Silent: How Cochlear Implants Help the Brain Rewire Itself

April 15, 2026 – Innsbruck, Austria: Single-Sided Deafness (SSD) has long been underestimated. Research clearly shows that hearing with only one ear entails significant limitations and results in measurable changes in the brain. New scientific insights and advancements in cochlear implant (CI) technology offer real opportunities to reverse many of these effects.

• Single-Sided Deafness (SSD) is far more than hearing with one ear. It triggers neuroplastic changes in the brain.
• SSD affects daily life: no sound localization, reduced speech understanding, and increased listening effort.
• Cochlear implants are currently the only treatment that can restore binaural hearing, helping to counteract SSD-related disadvantages and limit or partially reverse cortical reorganization.

Living With One Hearing Ear: A Daily Challenge

Losing binaural hearing – the ability to hear with both ears – has far reaching consequences. Directional hearing is severely limited, making it difficult or impossible to determine where sounds are coming from or how far away they are. Speech understanding, particularly in noisy environments, is significantly reduced, as the brain can no longer rely on input from both ears to filter and process sound effectively. As a result, people with Single Sided Deafness (SSD) often report high levels of listening fatigue in everyday situations such as classrooms, meetings, or restaurants. Many experience difficulties participating in group conversations, feel less secure in traffic, and gradually withdraw from social activities due to the constant effort required to listen and communicate.

Reorganization of the Brain

Neuroscience provides a clear explanation for many of the challenges associated with Single Sided Deafness. After the loss of hearing on one side, the auditory cortex undergoes significant neuroplastic reorganization due to the lack of balanced input from both ears. Auditory brain areas that no longer receive stimulation from the deaf ear may be taken over by the hearing ear or even reassigned to other sensory modalities, such as vision or touch. As a result, listening becomes more effortful, a change that can be measured objectively and is often experienced as mental fatigue in everyday situations. These neuroplastic changes occur in both children and adults, although at different speeds. Single Sided Deafness is particularly critical in early childhood, when neural networks are still developing and reorganize especially rapidly, potentially leading to long lasting effects if auditory input is not restored.

Cochlear Implants for True Binaural Hearing

For SSD, several treatment options exist, but not all can restore binaural hearing. CROS and bone-conduction systems route sound from the deaf to the hearing ear. While this improves loudness, it does not support directional hearing or accurate distance perception; hearing remains monaural.
A cochlear implant is currently the only option that stimulates the deaf ear and enables true binaural hearing. Clinical experience and current research show:

• Neural changes caused by SSD can be partially reversed with a CI, even after long duration of deafness.
• For children with SSD, early implantation is essential, as it can prevent long-term reorganisation of auditory pathways and support normal speech and social development.
• Many CI users regain excellent sound localization abilities within months of activation.
• Tinnitus is significantly reduced.
  

Dr. Reinhold Schatzer, specialist in sound coding and signal processing at MED EL and a renowned SSD expert, highlights the importance of neuroplastic learning: “The human brain is made for binaural hearing. After SSD, once it receives input from both sides again, it starts to relearn lost skills. With a cochlear implant, we have observed the reorganization of neural patterns even after many years of Single-Sided Deafness.”

Convincing Outcomes for Children and Adults

Since cochlear implants for SSD became a reimbursed treatment option in 2013, an increasing number of people have chosen a CI. Both children and adults benefit from better speech understanding, reduced listening effort, improved safety in daily life, and better academic and career opportunities.
One of them is Kylie, who reports: “I can locate sound and orient to it, which is useful for safety like crossing roads and people calling me. I am delighted to be able to play, talk and sing with my children again. Before getting my implant, I had started to feel very isolated and disengaged from group settings. Now I no longer need to manipulate a room to have people sitting on my good hearing side, and I can hear well at noisy environments, so I have been able to get back to the joy of life, socialising, going to restaurants, parties, quiz nights, concerts…and I am no longer talking too loudly to people!”

Single-Sided Deafness is far more than “hearing with only one ear.” It significantly impacts everyday life – and modern cochlear implant technology can help address many of its consequences.

Factbox:

Single-Sided Deafness (SSD)

• Single-Sided Deafness (SSD) is a severe to profound hearing loss in one ear, while the other ear hears normally.
• SSD is more than hearing with one ear: it impairs sound localization, speech understanding in noise, and increases listening effort.
• The brain adapts to SSD: missing auditory input leads to neuroplastic reorganization, increasing fatigue and reducing hearing efficiency.
• CROS and bone conduction systems reroute sound to the hearing ear but do not restore binaural hearing.
• Cochlear implants are currently the only treatment that stimulates the deaf ear and enables true binaural hearing.
• Early treatment, especially in children, is crucial to support normal auditory development and avoid long term cortical changes.
  Further information about SSD and hearing solutions can be found on the MED‑EL website.

Author: Carmen Kronawettleitner, Senior Project Manager, Text & Translations, Corporate Communications & Awareness

About MED-EL

MED-EL Medical Electronics, a leader in implantable hearing solutions, is driven by a mission to overcome hearing loss as a barrier to communication and quality of life. The Austrian-based, privately owned business was co-founded by industry pioneers Ingeborg and Erwin Hochmair, whose ground-breaking research led to the development of the world’s first micro-electronic multi-channel cochlear implant (CI), which was successfully implanted in 1977 and was the basis for what is known as the modern CI today. This laid the foundation for the successful growth of the company in 1990, when they hired their first employees. To date, MED-EL has more than 3,100 employees from around 90 nations and 30 locations worldwide.
The company offers the widest range of implantable and non-implantable solutions to treat all types of hearing loss, enabling people in 140 countries enjoy the gift of hearing with the help of a MED-EL device. MED-EL’s hearing solutions include cochlear and middle ear implant systems, a combined electric acoustic stimulation hearing implant system, auditory brainstem implants as well as surgical and non-surgical bone conduction devices. www.medel.com 

CEO

Doz. DI Dr DDr med. h.c. Ingeborg Hochmair

Press Contact

PR & Corporate Communications
MED-EL Medical Electronics
Fürstenweg 77a
6020 Innsbruck
Austria
T: +43 5 7788
E: [email protected]